Market revenue in 2023 | USD 237.3 million |
Market revenue in 2030 | USD 345.4 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Crt-defibrillator |
Fastest growing segment | CRT-Pacemaker |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | CRT-Defibrillator, CRT-Pacemaker |
Key market players worldwide | Medtronic PLC, Abbott Laboratories, Boston Scientific Corp, BIOTRONIK, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac resynchronization therapy market will help companies and investors design strategic landscapes.
Crt-defibrillator was the largest segment with a revenue share of 53.01% in 2023. Horizon Databook has segmented the Germany cardiac resynchronization therapy market based on crt-defibrillator, crt-pacemaker covering the revenue growth of each sub-segment from 2018 to 2030.
The German cardiac resynchronization therapy market held a large share of the European market during 2021. The factors contributing to this large share are presence of key market players, high awareness & adoption of treatment for congestive heart failure, and advanced healthcare infrastructure. BIOTRONIK SE & Co. KG, for instance, is headquartered in Germany and is one of the leading companies in the global CRT market.
The company’s CRT defibrillator lineup includes Acticor, Rivacor, Intica, Inlexa, Iforia, Inventra, and Itrevia devices. CRT pacemakers from Biotronik are Enticos, Edora, Enitra, Evity, Entovis, Epyra, and Etrinsa devices. The company’s CRT-D and CRT-P portfolios have enhanced features such as remote monitoring and MRI compatibility.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany cardiac resynchronization therapy market , including forecasts for subscribers. This country databook contains high-level insights into Germany cardiac resynchronization therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account